UNSPSC 51393312: Norbudrine

This classification denotes a beta-adrenergic agonist with the molecular formula C12H17NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8P6T83567P, chemically known as 2-cyclobutylamino-1-(3,4-dihydroxyphenyl)ethanol but generally known as norbudrine, which bears US NIH Compound Identifier 166575. European Medicines Agency schedules Norbudrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09355MIG.

UNSPSC 51393312 Norbudrine is a Commodity code that captures pharmaceutical products procured by state and local health agencies, specifically naloxone and related drug-deactivation systems for emergency response and community health programs. State and local governments are buying these products primarily through health departments and county public health offices to support overdose-prevention initiatives and substance-abuse response. The issuing bodies soliciting under this code include county health agencies and state health and human services commissions, which typically procure naloxone in bulk quantities with standardized delivery schedules to centralized community health facilities or pharmacy benefit programs.

Recent activity shows solicitation from Seminole County, Florida, which issued an IFB (Solicitation Number IFB60459723LAS, posted June 30, 2026, response deadline July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The Texas Health and Human Services Commission posted a Request for Information (RFI No. HHS0017013, posted April 3, 2026) exploring direct-to-manufacturer prescription fulfillment models for its Therapeutic Pharmacy Initiative, signaling state-level interest in streamlined pharmaceutical procurement outside traditional pharmacy benefit manager and wholesale channels. Geographic activity centers in Florida and Texas. Vendors responding to these solicitations must comply with federal requirements including E-Verify employment verification, drug-free workplace certification, and federal environmental regulations when FEMA funding is involved, and must carry workers' compensation and professional liability insurance.